Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice

Frontiers in Microbiology

Volumn 6, Issue APR, 2015, Pages

  Obata, Fumiko ^a,b   Subrahmanyam, Priyanka B ^a   Vozenilek, Aimee E ^a   Hippler, Lauren M ^a   Jeffers, Tynae ^a   Tongsuk, Methinee ^a   Tiper, Irina ^a   Saha, Progyaparamita ^a   Jandhyala, Dakshina M ^c   Kolling, Glynis L ^d   Latinovic, Olga ^a   Webb, Tonya J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cytokines; Escherichia coli; Hemolytic uremic syndrome; Mouse models; Natural killer T cell; Shiga toxin; Single molecule imaging; STORM TIRF

Indexed keywords

ALBUMIN; CD1D ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; VEROTOXIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEATH; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLOMERULUS; IMMUNOFLUORESCENCE TEST; KIDNEY FAILURE; MALE; MOLECULAR PATHOLOGY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; SURVIVAL; UREA NITROGEN BLOOD LEVEL; URINALYSIS; WEIGHT REDUCTION;

ESCHERICHIA COLI; MURINAE; MUS;

EID: 84930938227     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00262     Document Type: Article

References (56)

1. Ake, J. A., Jelacic, S., Ciol, M. A., Watkins, S. L., Murray, K. F., Christie, D. L., et al. (2005). Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115, e673-e680. doi: 10.1542/peds.2004-2236.
2. Akis, N., and Madaio, M. P. (2004). Isolation, culture, and characterization of endothelial cells from mouse glomeruli. Kidney Int. 65, 2223-2227. doi: 10.1111/j.1523-1755.2004.00634.x.
3. Berzins, S. P., Smyth, M. J., and Baxter, A. G. (2011). Presumed guilty: natural killer T cell defects and human disease. Nat. Rev. Immunol. 11, 131-142. doi: 10.1038/nri2904.
4. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E., and Brenner, M. B. (2003). Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4, 1230-1237. doi: 10.1038/ni1002.
5. Brutkiewicz, R. R., Bennink, J. R., Yewdell, J. W., and Bendelac, A. (1995). TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD1.1. J. Exp. Med. 182, 1913-1919. doi: 10.1084/jem.182.6.1913.
6. Burdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., et al. (1998). Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J. Immunol. 161, 3271-3281.
7. Carnaud, C., Lee, D., Donnars, O., Park, S. H., Beavis, A., Koezuka, Y., et al. (1999). Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163, 4647-4650.
8. Chang, Y. J., Huang, J. R., Tsai, Y. C., Hung, J. T., Wu, D., Fujio, M., et al. (2007). Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Proc. Natl. Acad. Sci. U.S.A. 104, 10299-10304. doi: 10.1073/pnas.0703824104.
9. Chen, H., Huang, H., and Paul, W. E. (1997). NK1.1+ CD4+ T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 158, 5112-5119.
10. Dempsey, G. T., Vaughan, J. C., Chen, K. H., Bates, M., and Zhuang, X. (2011). Evaluation of fluorophores for optimal performance in localization-based super-resolution imaging. Nat. Methods 8, 1027-1036. doi: 10.1038/nmeth.1768.
11. Dervenoulas, J., Tsirigotis, P., Bollas, G., Pappa, V., Xiros, N., Economopoulos, T., et al. (2000). Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases. Ann. Hematol. 79, 66-72. doi: 10.1007/s002770050012.
12. Donohue-Rolfe, A., Acheson, D. W., Kane, A. V., and Keusch, G. T. (1989). Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies. Infect. Immun. 57, 3888-3893.
13. Fernandez, G. C., Gomez, S. A., Rubel, C. J., Bentancor, L. V., Barrionuevo, P., Alduncin, M., et al. (2005). Impaired neutrophils in children with the typical form of hemolytic uremic syndrome. Pediatr. Nephrol. 20, 1306-1314. doi: 10.1007/s00467-005-1906-9.
14. Fernandez, G. C., Lopez, M. F., Gomez, S. A., Ramos, M. V., Bentancor, L. V., Fernandez-Brando, R. J., et al. (2006). Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin. Exp. Immunol. 146, 76-84. doi: 10.1111/j.1365-2249.2006.03155.x.
15. Gianantonio, C. A., Vitacco, M., Mendilaharzu, F., Gallo, G. E., and Sojo, E. T. (1973). The hemolytic-uremic syndrome. Nephron 11, 174-192. doi: 10.1159/000180229.
16. Hua, J., Liang, S., Ma, X., Webb, T. J., Potter, J. P., and Li, Z. (2011). The interaction between regulatory T cells and NKT cells in the liver: a CD1d bridge links innate and adaptive immunity. PLoS ONE 6:e27038. doi: 10.1371/journal.pone.0027038.
17. Karmali, M. A., Petric, M., Lim, C., Fleming, P. C., Arbus, G. S., and Lior, H. (1985). The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 151, 775-782. doi: 10.1093/infdis/151.5.775.
18. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., et al. (1997). CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278, 1626-1629. doi: 10.1126/science.278.5343.1626.
19. Keepers, T. R., Gross, L. K., and Obrig, T. G. (2007). Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome. Infect. Immun. 75, 1229-1236. doi: 10.1128/IAI.01663-06.
20. Keepers, T. R., Psotka, M. A., Gross, L. K., and Obrig, T. G. (2006). A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J. Am. Soc. Nephrol. 17, 3404-3414. doi: 10.1681/ASN.2006050419.
21. Kronenberg, M., and Gapin, L. (2002). The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2, 557-568. doi: 10.1038/nri854.
22. Lantz, O., and Bendelac, A. (1994). An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8-T cells in mice and humans. J. Exp. Med. 180, 1097-1106. doi: 10.1084/jem.180.3.1097.
23. Liesche, J., Ziomkiewicz, I., and Schulz, A. (2013). Super-resolution imaging with Pontamine Fast Scarlet 4BS enables direct visualization of cellulose orientation and cell connection architecture in onion epidermis cells. BMC Plant Biol. 13:226. doi: 10.1186/1471-2229-13-226.
24. Lopez, E. L., Diaz, M., Grinstein, S., Devoto, S., Mendilaharzu, F., Murray, B. E., et al. (1989). Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J. Infect. Dis. 160, 469-475. doi: 10.1093/infdis/160.3.469.
25. Martin, D. L., Macdonald, K. L., White, K. E., Soler, J. T., and Osterholm, M. T. (1990). The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N. Engl. J. Med. 323, 1161-1167. doi: 10.1056/NEJM199010253231703.
26. Matsuda, J. L., Mallevaey, T., Scott-Browne, J., and Gapin, L. (2008). CD1d-restricted iNKT cells, the "Swiss-Army knife" of the immune system. Curr. Opin. Immunol. 20, 358-368. doi: 10.1016/j.coi.2008.03.018.
27. Mattner, J., Debord, K. L., Ismail, N., Goff, R. D., Cantu, C. III., Zhou, D., et al. (2005). Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529. doi: 10.1038/nature03408.
28. Morigi, M., Buelli, S., Zanchi, C., Longaretti, L., Macconi, D., Benigni, A., et al. (2006). Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am. J. Pathol. 169, 1965-1975. doi: 10.2353/ajpath.2006.051331.
29. Mundel, P., Reiser, J., Zuniga Mejia Borja, A., Pavenstadt, H., Davidson, G. R., Kriz, W., et al. (1997). Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 236, 248-258. doi: 10.1006/excr.1997.3739.
30. Murata, A., Shimazu, T., Yamamoto, T., Taenaka, N., Nagayama, K., Honda, T., et al. (1998). Profiles of circulating inflammatory-and anti-inflammatory cytokines in patients with hemolytic uremic syndrome due to E. coli O157 infection. Cytokine 10, 544-548. doi: 10.1006/cyto.1997.0329.
31. Nakamatsu, M., Yamamoto, N., Hatta, M., Nakasone, C., Kinjo, T., Miyagi, K., et al. (2007). Role of interferon-gamma in Valpha14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. Microbes Infect. 9, 364-374. doi: 10.1016/j.micinf.2006.12.003.
32. Ostroff, S. M., Tarr, P. I., Neill, M. A., Lewis, J. H., Hargrett-Bean, N., and Kobayashi, J. M. (1989). Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J. Infect. Dis. 160, 994-998. doi: 10.1093/infdis/160.6.994.
33. Park, S. H., Guy-Grand, D., Lemonnier, F. A., Wang, C. R., Bendelac, A., and Jabri, B. (1999). Selection and expansion of CD8alpha/alpha(1) T cell receptor alpha/beta(1) intestinal intraepithelial lymphocytes in the absence of both classical major histocompatibility complex class I and nonclassical CD1 molecules. J. Exp. Med. 190, 885-890. doi: 10.1084/jem.190.6.885.
34. Perez, N., Spizzirri, F., Rahman, R., Suarez, A., Larrubia, C., and Lasarte, P. (1998). Steroids in the hemolytic uremic syndrome. Pediatr. Nephrol. 12, 101-104. doi: 10.1007/s004670050413.
35. Petruzziello-Pellegrini, T. N., Yuen, D. A., Page, A. V., Patel, S., Soltyk, A. M., Matouk, C. C., et al. (2012). The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J. Clin. Invest. 122, 759-776. doi: 10.1172/JCI57313.
36. Proulx, F., Turgeon, J. P., Litalien, C., Mariscalco, M. M., Robitaille, P., and Seidman, E. (1998). Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome. Pediatr. Infect. Dis. J. 17, 899-904. doi: 10.1097/00006454-199810000-00010.
37. Psotka, M. A., Obata, F., Kolling, G. L., Gross, L. K., Saleem, M. A., Satchell, S. C., et al. (2009). Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect. Immun. 77, 959-969. doi: 10.1128/IAI.00679-08.
38. Ramegowda, B., and Tesh, V. L. (1996). Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect. Immun. 64, 1173-1180.
39. Ramos, M. V., Fernandez, G. C., Patey, N., Schierloh, P., Exeni, R., Grimoldi, I., et al. (2007). Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome. Blood 109, 2438-2445. doi: 10.1182/blood-2006-06-026997.
40. Roberts, T. J., Sriram, V., Spence, P. M., Gui, M., Hayakawa, K., Bacik, I., et al. (2002). Recycling CD1d1 molecules present endogenous antigens processed in an endocytic compartment to NKT cells. J. Immunol. 168, 5409-5414. doi: 10.4049/jimmunol.168.11.5409.
41. Robson, W. L., Leung, A. K., Trevenen, C. L., and Brant, R. (1993). Diarrhea-associated hemolytic uremic syndrome. Can. Fam. Physician 39, 2139-2145.
42. Roche, J. K., Keepers, T. R., Gross, L. K., Seaner, R. M., and Obrig, T. G. (2007). CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation. Am. J. Pathol. 170, 526-537. doi: 10.2353/ajpath.2007.060366.
43. Ryan, C. A., Tauxe, R. V., Hosek, G. W., Wells, J. G., Stoesz, P. A., Mcfadden, H. W. Jr., et al. (1986). Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings. J. Infect. Dis. 154, 631-638. doi: 10.1093/infdis/154.4.631.
44. Sauter, K. A., Melton-Celsa, A. R., Larkin, K., Troxell, M. L., O'brien, A. D., and Magun, B. E. (2008). Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody. Infect. Immun. 76, 4469-4478. doi: 10.1128/IAI.00592-08.
45. Sekine, M., Monkawa, T., Morizane, R., Matsuoka, K., Taya, C., Akita, Y., et al. (2012). Selective depletion of mouse kidney proximal straight tubule cells causes acute kidney injury. Transgenic Res. 21, 51-62. doi: 10.1007/s11248-011-9504-z.
46. Shimizu, M., Kuroda, M., Sakashita, N., Konishi, M., Kaneda, H., Igarashi, N., et al. (2012). Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome. Cytokine 60, 694-700. doi: 10.1016/j.cyto.2012.07.038.
47. Shiraishi, M., Ichiyama, T., Matsushige, T., Iwaki, T., Iyoda, K., Fukuda, K., et al. (2008). Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy. J. Neuroimmunol. 196, 147-152. doi: 10.1016/j.jneuroim.2008.02.012.
48. Smyth, J. W., and Shaw, R. M. (2008). Visualizing ion channel dynamics at the plasma membrane. Heart Rhythm 5, S7-S11. doi: 10.1016/j.hrthm.2008.02.015.
49. Stearns-Kurosawa, D. J., Collins, V., Freeman, S., Tesh, V. L., and Kurosawa, S. (2010). Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli. Infect. Immun. 78, 2497-2504. doi: 10.1128/IAI.01435-09.
50. Stearns-Kurosawa, D. J., Oh, S. Y., Cherla, R. P., Lee, M. S., Tesh, V. L., Papin, J., et al. (2013). Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome. Am. J. Pathol. 182, 1227-1238. doi: 10.1016/j.ajpath.2012.12.026.
51. Stone, S. M., Thorpe, C. M., Ahluwalia, A., Rogers, A. B., Obata, F., Vozenilek, A., et al. (2012). Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib. Front. Cell. Infect. Microbiol. 2:135. doi: 10.3389/fcimb.2012.00135.
52. Su, C., and Brandt, L. J. (1995). Escherichia coli O157:H7 infection in humans. Ann. Intern. Med. 123, 698-714. doi: 10.7326/0003-4819-123-9-199511010-00009.
53. Valles Pg, M. S., Gonzalez, A., Manucha, W., Bocanegra, V., and Valles, R. (2012). Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome. Pediatr. Nephrol. 27, 407-415. doi: 10.1007/s00467-011-2014-7.
54. Webb, T. J., Giuntoli, R. L. II., Rogers, O., Schneck, J., and Oelke, M. (2008). Ascites specific inhibition of CD1d-mediated activation of natural killer T cells. Clin. Cancer Res. 14, 7652-7658. doi: 10.1158/1078-0432.CCR-08-1468.
55. Webb, T. J., Litavecz, R. A., Khan, M. A., Du, W., Gervay-Hague, J., Renukaradhya, G. J., et al. (2006). Inhibition of CD1d1-mediated antigen presentation by the vaccinia virus B1R and H5R molecules. Eur. J. Immunol. 36, 2595-2600. doi: 10.1002/eji.200636024.
56. Zanchi, C., Zoja, C., Morigi, M., Valsecchi, F., Liu, X. Y., Rottoli, D., et al. (2008). Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin. J. Immunol. 181, 1460-1469. doi: 10.4049/jimmunol.181.2.1460.